Stock comparison
Intellia Therapeutics, Inc. is 1.0x more valuable than NEOGEN CORP by market capitalization ($2.16 B vs $2.12 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
NTLA is larger
Intellia Therapeutics, Inc. is 1.0x more valuable than NEOGEN CORP by market capitalization ($2.16 B vs $2.12 B).
Market value leader
NTLA
Intellia Therapeutics, Inc. is 1.0x more valuable than NEOGEN CORP by market capitalization ($2.16 B vs $2.12 B).
Revenue leader
NEOG
NTLA: $67.67M vs NEOG: $894.66M.
Profit leader
NTLA
NTLA: -$412.69M vs NEOG: -$1.09B.
Margin leader
NEOG
NTLA: -609.9% vs NEOG: -122.1% net margin.
| Metric | NTLA | NEOG |
|---|---|---|
| Market cap | $2.16 B | $2.12 B |
| US-listed rank | #2076 | #2092 |
| Revenue (latest FY) | $67.67M | $894.66M |
| Net income (latest FY) | -$412.69M | -$1.09B |
| Net margin | -609.9% | -122.1% |
| P/E (trailing FY) | - | - |
| SEC filings | 679 | 1,894 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
Intellia Therapeutics, Inc. is 1.0x more valuable than NEOGEN CORP by market capitalization ($2.16 B vs $2.12 B).
In their latest fiscal years, Intellia Therapeutics, Inc. reported $67.67M in revenue while NEOGEN CORP reported $894.66M.
Full pages: Intellia Therapeutics, Inc. and NEOGEN CORP, or browse the full rankings.